N Jewel Samadder Selected Research

Neoplasms (Cancer)

11/2023	Methylated DNA Markers for Sporadic Colorectal and Endometrial Cancer Are Strongly Associated with Lynch Syndrome Cancers.
10/2023	Prospective and Mendelian randomization analyses on the association of circulating fatty acid binding protein 4 (FABP-4) and risk of colorectal cancer.
1/2023	Phase II trial of weekly erlotinib dosing to reduce duodenal polyp burden associated with familial adenomatous polyposis.
12/2019	Hereditary Polyposis Syndromes.
1/2019	Family History Associates With Increased Risk of Colorectal Cancer in Patients With Inflammatory Bowel Diseases.
1/2018	Chemoprevention with Cyclooxygenase and Epidermal Growth Factor Receptor Inhibitors in Familial Adenomatous Polyposis Patients: mRNA Signatures of Duodenal Neoplasia.
1/2018	Association of Sulindac and Erlotinib vs Placebo With Colorectal Neoplasia in Familial Adenomatous Polyposis: Secondary Analysis of a Randomized Clinical Trial.
8/2017	Outcomes and complications of radiation therapy in patients with familial adenomatous polyposis.
3/2016	Effect of Sulindac and Erlotinib vs Placebo on Duodenal Neoplasia in Familial Adenomatous Polyposis: A Randomized Clinical Trial.
12/2015	Increased Risk of Colorectal Cancer Among Family Members of All Ages, Regardless of Age of Index Case at Diagnosis.

For more, sign up at right for free...

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

N Jewel Samadder Research Topics

Disease

12	Neoplasms (Cancer) 11/2023 - 04/2014
12	Adenomatous Polyposis Coli (Familial Adenomatous Polyposis) 01/2023 - 03/2015
9	Polyps 01/2023 - 03/2016
8	Colorectal Neoplasms (Colorectal Cancer) 11/2023 - 04/2011
4	Hereditary Nonpolyposis Colorectal Neoplasms (Hereditary Nonpolyposis Colorectal Cancer) 11/2023 - 03/2015
4	Adenoma (Adenomas) 04/2022 - 04/2014
2	Disease Progression 04/2022 - 10/2020
2	Colonic Neoplasms (Colon Cancer) 02/2016 - 12/2012
1	Endometrial Neoplasms (Endometrial Cancer) 11/2023
1	Inflammation (Inflammations) 10/2023
1	Insulin Resistance 10/2023
1	Obesity 10/2023
1	Duodenal Neoplasms (Duodenal Cancer) 07/2018
1	Acne Vulgaris 03/2016
1	Exanthema (Rash) 03/2016
1	Rectal Neoplasms (Rectal Cancer) 02/2016
1	Diverticular Diseases 09/2014
1	Inflammatory Bowel Diseases (Inflammatory Bowel Disease) 04/2011

Drug/Important Bio-Agent (IBA)

8	Sulindac (Copal)FDA LinkGeneric 01/2023 - 03/2016
7	Calcibiotic Root Canal SealerIBA 12/2019 - 04/2014
5	Erlotinib Hydrochloride (CP 358,774)FDA Link 01/2023 - 03/2016
3	Eflornithine (Ornidyl)FDA Link 04/2022 - 08/2016
2	Biomarkers (Surrogate Marker)IBA 11/2023 - 01/2018
2	SaltsIBA 01/2018 - 03/2016
1	DNA (Deoxyribonucleic Acid)IBA 11/2023
1	Genetic Markers (Genetic Marker)IBA 11/2023
1	Fatty Acid-Binding ProteinsIBA 10/2023
1	AdipokinesIBA 10/2023
1	Fatty Acids (Saturated Fatty Acids)IBA 10/2023
1	LipidsIBA 10/2023
1	Naproxen (Naprosyn)FDA LinkGeneric 01/2021
1	ErbB Receptors (EGF Receptor)IBA 01/2018
1	Drug CombinationsIBA 01/2018
1	Prostaglandin-Endoperoxide Synthases (Cyclooxygenase)IBA 01/2018
1	RNA (Ribonucleic Acid)IBA 01/2018
1	Messenger RNA (mRNA)IBA 01/2018
1	Dinoprostone (PGE2)FDA Link 01/2018
1	Interleukin-12 (IL 12)IBA 01/2018
1	6-chloro-2-(1-piperazinyl)pyrazine (CPP)IBA 08/2016
1	PolyaminesIBA 08/2016
1	MucinsIBA 03/2016
1	ORALIT (ORS)IBA 02/2016
1	Hydroxymethylglutaryl-CoA Reductase Inhibitors (HMG-CoA Reductase Inhibitors)IBA 04/2011
1	Non-Steroidal Anti-Inflammatory Agents (NSAIDs)IBA 04/2011

Therapy/Procedure

5	Colectomy 04/2022 - 08/2016
4	Chemoprevention 01/2021 - 03/2016
3	Therapeutics 04/2022 - 08/2016
2	Restorative Proctocolectomy 04/2022 - 01/2018
1	Endoscopes 12/2019
1	Radiotherapy 08/2017
1	Stents 12/2012